USPTO Examiner BOGGS RUSSELL T - Art Unit 1663

Recent Applications

Detailed information about the 100 most recent patent applications.

Application NumberTitleFiling DateDisposal DateDispositionTime (months)Office ActionsRestrictionsInterviewAppeal
18678690Plant promoter for transgene expressionMay 2024February 2025Allow800NoNo
18628578NOVEL INSECT INHIBITORY PROTEINSApril 2024May 2025Allow1311YesNo
18404398MODIFIED PLANT ENDOSPERM SPECIFIC PROMOTER AND USE THEREOFJanuary 2024November 2024Allow1020NoNo
18319022PESTICIDAL TOXIN PROTEINS ACTIVE AGAINST LEPIDOPTERAN INSECTSMay 2023December 2024Allow1900NoNo
18032130MODIFIED PLANT ENDOSPERM SPECIFIC PROMOTER AND USE THEREOFMay 2023January 2024Allow910YesNo
18299406TRANSGENIC PLANTS HAVING ALTERED BIOMASS COMPOSITIONApril 2023May 2025Allow2520NoNo
18068377PROMOTER, PROMOTER CONTROL ELEMENTS, AND COMBINATIONS, AND USES THEREOFDecember 2022May 2025Allow2910YesNo
18067581PROMOTER, PROMOTER CONTROL ELEMENTS, AND COMBINATIONS, AND USES THEREOFDecember 2022April 2025Allow2810YesNo
17949633SOYBEAN CULTIVAR 11232411September 2022April 2025Allow3110NoNo
17933203MODIFIED Cry1Ca TOXINS USEFUL FOR CONTROL OF INSECT PESTSSeptember 2022May 2025Allow3110NoNo
17946330SOYBEAN CULTIVAR 13070448September 2022April 2025Allow3110NoNo
17943979SOYBEAN CULTIVAR 13320228September 2022March 2025Allow3010NoNo
17943950SOYBEAN CULTIVAR 11210228September 2022March 2025Allow3010NoNo
17943933SOYBEAN CULTIVAR 16180107September 2022March 2025Allow3010NoNo
17941982SOYBEAN CULTIVAR 16430401September 2022June 2025Abandon3310NoNo
17939753SOYBEAN CULTIVAR 18040512September 2022April 2025Allow3110NoNo
17817486TRANSGENIC PLANTS WITH ENHANCED TRAITSAugust 2022June 2025Allow3421NoNo
17808786MAIZE HYBRID X00V039June 2022May 2025Allow3420NoNo
17808732MAIZE HYBRID X90V909June 2022April 2025Allow3310YesNo
17807483MAIZE INBRED 1PQLK32June 2022May 2025Allow3430NoNo
17721492SCREENING METHODSApril 2022June 2025Abandon3810NoNo
17721973INBRED CORN LINE KW7FP1748April 2022November 2024Allow3110NoNo
17677238COMPOSITIONS AND METHODS FOR DETERRING FEEDING BY PSYLLIDSFebruary 2022March 2025Abandon3710NoNo
17587178SOYBEAN VARIETY 5PQWR03January 2022January 2025Allow3620NoNo
17575318NOVEL INSECT INHIBITORY PROTEINSJanuary 2022January 2024Allow2400NoNo
17645631REGULATORY SEQUENCES FOR MODULATING TRANSGENE EXPRESSION IN PLANTSDecember 2021December 2024Allow3611NoNo
175383223'UTR SEQUENCE FOR TRANSGENE EXPRESSIONNovember 2021March 2024Allow2810NoNo
17532872Plants and Seeds of Hybrid Corn Variety CH011198November 2021March 2024Allow2810NoNo
17530024Plants and Seeds of Corn Variety CV527145November 2021April 2024Allow2910NoNo
17528691Plants and Seeds of Corn Variety CV515661November 2021April 2024Allow2910NoNo
17526107METHOD FOR MODIFYING THE RESISTANCE PROFILE OF SPINACIA OLERACEA TO DOWNY MILDEWNovember 2021August 2024Abandon3301NoNo
17524442Plants and Seeds of Hybrid Corn Variety CH011015November 2021April 2024Allow2910NoNo
17522107SOYBEAN CULTIVAR 06142425November 2021January 2025Allow3810NoNo
17522821Plants and Seeds of Hybrid Corn Variety CH010982November 2021February 2024Allow2710NoNo
17517250Plants and Seeds of Hybrid Corn Variety CH011227November 2021August 2024Allow3310NoNo
17513950Plants and Seeds of Hybrid Corn Variety CH011004October 2021February 2024Allow2710NoNo
17512614NOVEL INTERGENIC SEQUENCE REGIONS AND USES THEREOFOctober 2021March 2025Allow4111NoNo
17512273Plants and Seeds of Hybrid Corn Variety CH011156October 2021October 2024Allow3610NoNo
17509373Plants and Seeds of Hybrid Corn Variety CH011166October 2021August 2024Allow3410NoNo
17451882MAIZE INBRED PH48YSOctober 2021February 2024Allow2810NoNo
17451892MAIZE HYBRID X75P905October 2021May 2024Allow3010NoNo
17488189PLANT REGULATORY ELEMENTS AND USES THEREOFSeptember 2021July 2024Allow3311NoNo
17478394CANOLA INBRED NS7206September 2021September 2023Allow2410YesNo
17478124CANOLA HYBRID 19GS2321ISeptember 2021September 2023Allow2410NoNo
17468456Methods and Compositions for Peronospora Resistance in SpinachSeptember 2021August 2024Abandon3510NoNo
17461517SOYBEAN CULTIVAR 09030215August 2021December 2022Abandon1510NoNo
17461445Hybrid Seed Potato BreedingAugust 2021June 2025Allow4520YesNo
17459034ISOLATED TRANSCRIPTION FACTORS OF CARICA PAPAYA AND THEIR APPLICATION TO OBTAIN EXTREME TEMPERATURE TOLERATING PLANTSAugust 2021October 2023Allow2500YesNo
17459304TRANSGENIC PLANTS HAVING INCREASED BIOMASSAugust 2021March 2025Allow4340YesNo
17459770Isolated Novel Nucleic Acid and Protein Molecules from Soybeans and Methods of Using Those Molecules to Generate Transgenic Plants With Enhanced Agronomic TraitsAugust 2021July 2024Abandon3511NoNo
17446040METHOD and/or COMPOSITIONS FOR LETTUCE (LACTUCA SATIVA) BREEDING and/or VARIETIES DEVELOPED THEREBYAugust 2021February 2025Abandon4120YesNo
17401853LETTUCE VARIETY NUN 09153 LTLAugust 2021September 2023Abandon2510NoNo
17377494MAIZE HYBRID X15R402July 2021August 2023Allow2510NoNo
17377742MAIZE HYBRID X00R828July 2021August 2023Allow2510NoNo
17377478MAIZE HYBRID X15R414July 2021August 2023Allow2510NoNo
17377489MAIZE HYBRID X15R405July 2021August 2023Allow2510NoNo
17377659MAIZE HYBRID X05R385July 2021May 2023Allow2210NoNo
17377476MAIZE HYBRID X15R426July 2021July 2023Allow2410NoNo
17377453MAIZE HYBRID X85R242July 2021December 2023Allow2920YesNo
17377474MAIZE HYBRID X18R493July 2021July 2023Allow2410NoNo
17377484MAIZE HYBRID X15R412July 2021February 2024Allow3110NoNo
17377793MAIZE HYBRID X00R804CYJuly 2021September 2023Allow2610NoNo
17377645MAIZE HYBRID X05R388July 2021July 2023Allow2410NoNo
17377464MAIZE HYBRID X18R499July 2021July 2023Allow2410NoNo
17366104MAIZE INBRED 1PEEA63July 2021December 2022Allow1710YesNo
17366061MAIZE INBRED 1PQCD72July 2021January 2023Allow1810NoNo
17366194MAIZE INBRED 1PKER39July 2021February 2023Allow1910NoNo
17366059MAIZE INBRED 1PFHC43July 2021February 2023Allow1910NoNo
17366087MAIZE INBRED 1PZTR12July 2021March 2023Allow2010NoNo
17366063MAIZE INBRED PH4DBAJuly 2021January 2023Allow1810NoNo
17366113MAIZE INBRED 1PWMQ52July 2021May 2023Allow2310NoNo
17366064MAIZE INBRED 1PCBY70July 2021February 2023Allow1910NoNo
17366126MAIZE INBRED 1PFLQ21July 2021February 2023Allow1910NoNo
17366062MAIZE INBRED 1PFKS71July 2021January 2023Allow1810NoNo
17329940PESTICIDAL GENES AND METHODS OF USEMay 2021March 2024Allow3411NoNo
17328962HEMP CULTIVAR NAMED '05.09.24.S1'May 2021April 2022Allow1110NoNo
17328883INSECTICIDAL PROTEIN DISCOVERY PLATFORM AND INSECTICIDAL PROTEINS DISCOVERED THEREFROMMay 2021March 2024Allow3410NoNo
17229604PLANT REGULATORY ELEMENTS AND USES THEREOFApril 2021March 2024Allow3511NoNo
17218737PLANT REGULATORY ELEMENTS AND METHODS OF USE THEREOFMarch 2021October 2023Allow3111NoNo
17218258VARIETY CORN LINE GIE2002March 2021March 2023Allow2310NoNo
17199789PERONOSPORA RESISTANCE IN SPINACIA OLERACEAMarch 2021April 2023Abandon2610NoNo
17182657HAPLOID EMBRYOGENESISFebruary 2021May 2025Allow5112NoNo
17180369RESISTANCE TO SOYBEAN CYST NEMATODE THROUGH GENE EDITINGFebruary 2021June 2024Allow4020YesNo
17175774ISOLATED POLYNUCLEOTIDES AND POLYPEPTIDES, AND METHODS OF USING SAME FOR INCREASING PLANT YIELD AND/OR AGRICULTURAL CHARACTERISTICSFebruary 2021April 2024Abandon3810NoNo
17175777ISOLATED POLYNUCLEOTIDES AND POLYPEPTIDES, AND METHODS OF USING SAME FOR INCREASING PLANT YIELD AND/OR AGRICULTURAL CHARACTERISTICSFebruary 2021April 2024Abandon3810NoNo
17175479PLANT REGULATORY ELEMENTS AND USES THEREOFFebruary 2021August 2023Allow3011NoNo
17166249COMPOSITIONS AND METHODS FOR CONTROLLING PLANT PESTSFebruary 2021March 2024Abandon3710YesNo
17165734Genetic Regulatory ElementsFebruary 2021November 2023Allow3320YesNo
17151856DOMINANT CRISPR INVERTED-REPEAT ALLELES TO DOWN-REGULATE GENE EXPRESSION IN HETEROZYGOUS PLANTSJanuary 2021July 2024Allow4220YesNo
17149521COMPOSITIONS AND METHODS FOR PERONOSPORA RESISTANCE IN SPINACHJanuary 2021December 2024Abandon4730YesNo
17259537GREEN ALGAL BESTROPHIN BICARBONATE TRANSPORTERSJanuary 2021March 2025Allow5051YesNo
17257595Method of Obtaining Multileaflet Medicago Sativa Materials by Means of MsPALM1 Artificial Site-Directed MutantsJanuary 2021July 2022Abandon1810NoNo
17135402METHOD FOR INCREASING THE YIELD OF MICROALGAE AND PRODUCTS PRODUCED THEREBY, AN ALTERED CAM1 GENE AND POLYPEPTIDE, AND A NOVEL CHLAMYDOMONAS SP.December 2020April 2023Abandon2820NoNo
17254439THERMOSTABLE RUBISCO ACTIVASE AND USES THEREOFDecember 2020July 2022Abandon1910NoNo
16465697Method for Promoting Homologous RecombinationDecember 2020December 2021Allow3021YesNo
17116274SOYBEAN VARIETY 61425819December 2020April 2022Abandon1600NoNo
16972779NUCLEIC ACID CONSTRUCTS AND METHODS OF USING SAMEDecember 2020July 2023Allow3111YesNo
17058018PLANTS COMPRISING WHEAT G-TYPE CYTOPLASMIC MALE STERILITY RESTORER GENES AND USES THEREOFNovember 2020January 2024Abandon3710NoNo
17090413SOYBEAN VARIETY 5PUMF50November 2020April 2022Allow1810NoNo
17077236MAIZE HYBRID X70P202October 2020February 2023Allow2810YesNo

Appeals Overview

This analysis examines appeal outcomes and the strategic value of filing appeals for examiner BOGGS, RUSSELL T.

Patent Trial and Appeal Board (PTAB) Decisions

Total PTAB Decisions
2
Examiner Affirmed
2
(100.0%)
Examiner Reversed
0
(0.0%)
Reversal Percentile
1.0%
Lower than average

What This Means

With a 0.0% reversal rate, the PTAB affirms the examiner's rejections in the vast majority of cases. This reversal rate is in the bottom 25% across the USPTO, indicating that appeals face significant challenges here.

Strategic Value of Filing an Appeal

Total Appeal Filings
22
Allowed After Appeal Filing
4
(18.2%)
Not Allowed After Appeal Filing
18
(81.8%)
Filing Benefit Percentile
19.2%
Lower than average

Understanding Appeal Filing Strategy

Filing a Notice of Appeal can sometimes lead to allowance even before the appeal is fully briefed or decided by the PTAB. This occurs when the examiner or their supervisor reconsiders the rejection during the mandatory appeal conference (MPEP § 1207.01) after the appeal is filed.

In this dataset, 18.2% of applications that filed an appeal were subsequently allowed. This appeal filing benefit rate is in the bottom 25% across the USPTO, indicating that filing appeals is less effective here than in most other areas.

Strategic Recommendations

Appeals to PTAB face challenges. Ensure your case has strong merit before committing to full Board review.

Filing a Notice of Appeal shows limited benefit. Consider other strategies like interviews or amendments before appealing.

Examiner BOGGS, RUSSELL T - Prosecution Strategy Guide

Executive Summary

Examiner BOGGS, RUSSELL T works in Art Unit 1663 and has examined 592 patent applications in our dataset. With an allowance rate of 75.3%, this examiner has a below-average tendency to allow applications. Applications typically reach final disposition in approximately 30 months.

Allowance Patterns

Examiner BOGGS, RUSSELL T's allowance rate of 75.3% places them in the 33% percentile among all USPTO examiners. This examiner has a below-average tendency to allow applications.

Office Action Patterns

On average, applications examined by BOGGS, RUSSELL T receive 1.75 office actions before reaching final disposition. This places the examiner in the 51% percentile for office actions issued. This examiner issues a slightly above-average number of office actions.

Prosecution Timeline

The median time to disposition (half-life) for applications examined by BOGGS, RUSSELL T is 30 months. This places the examiner in the 39% percentile for prosecution speed. Prosecution timelines are slightly slower than average with this examiner.

Interview Effectiveness

Conducting an examiner interview provides a +12.4% benefit to allowance rate for applications examined by BOGGS, RUSSELL T. This interview benefit is in the 52% percentile among all examiners. Recommendation: Interviews provide an above-average benefit with this examiner and are worth considering.

Request for Continued Examination (RCE) Effectiveness

When applicants file an RCE with this examiner, 21.0% of applications are subsequently allowed. This success rate is in the 16% percentile among all examiners. Strategic Insight: RCEs show lower effectiveness with this examiner compared to others. Consider whether a continuation application might be more strategic, especially if you need to add new matter or significantly broaden claims.

After-Final Amendment Practice

This examiner enters after-final amendments leading to allowance in 49.6% of cases where such amendments are filed. This entry rate is in the 69% percentile among all examiners. Strategic Recommendation: This examiner shows above-average receptiveness to after-final amendments. If your amendments clearly overcome the rejections and do not raise new issues, consider filing after-final amendments before resorting to an RCE.

Pre-Appeal Conference Effectiveness

When applicants request a pre-appeal conference (PAC) with this examiner, 50.0% result in withdrawal of the rejection or reopening of prosecution. This success rate is in the 40% percentile among all examiners. Note: Pre-appeal conferences show below-average success with this examiner. Consider whether your arguments are strong enough to warrant a PAC request.

Appeal Withdrawal and Reconsideration

This examiner withdraws rejections or reopens prosecution in 84.6% of appeals filed. This is in the 75% percentile among all examiners. Of these withdrawals, 90.9% occur early in the appeal process (after Notice of Appeal but before Appeal Brief). Strategic Insight: This examiner frequently reconsiders rejections during the appeal process compared to other examiners. Per MPEP § 1207.01, all appeals must go through a mandatory appeal conference. Filing a Notice of Appeal may prompt favorable reconsideration even before you file an Appeal Brief.

Petition Practice

When applicants file petitions regarding this examiner's actions, 93.8% are granted (fully or in part). This grant rate is in the 95% percentile among all examiners. Strategic Note: Petitions are frequently granted regarding this examiner's actions compared to other examiners. Per MPEP § 1002.02(c), various examiner actions are petitionable to the Technology Center Director, including prematureness of final rejection, refusal to enter amendments, and requirement for information. If you believe an examiner action is improper, consider filing a petition.

Examiner Cooperation and Flexibility

Examiner's Amendments: This examiner makes examiner's amendments in 0.0% of allowed cases (in the 2% percentile). This examiner rarely makes examiner's amendments compared to other examiners. You should expect to make all necessary claim amendments yourself through formal amendment practice.

Quayle Actions: This examiner issues Ex Parte Quayle actions in 2.2% of allowed cases (in the 67% percentile). This examiner issues Quayle actions more often than average when claims are allowable but formal matters remain (MPEP § 714.14).

Prosecution Strategy Recommendations

Based on the statistical analysis of this examiner's prosecution patterns, here are tailored strategic recommendations:

  • Appeal filing as negotiation tool: This examiner frequently reconsiders rejections during the appeal process. Filing a Notice of Appeal may prompt favorable reconsideration during the mandatory appeal conference.

Relevant MPEP Sections for Prosecution Strategy

  • MPEP § 713.10: Examiner interviews - available before Notice of Allowance or transfer to PTAB
  • MPEP § 714.12: After-final amendments - may be entered "under justifiable circumstances"
  • MPEP § 1002.02(c): Petitionable matters to Technology Center Director
  • MPEP § 1004: Actions requiring primary examiner signature (allowances, final rejections, examiner's answers)
  • MPEP § 1207.01: Appeal conferences - mandatory for all appeals
  • MPEP § 1214.07: Reopening prosecution after appeal

Important Disclaimer

Not Legal Advice: The information provided in this report is for informational purposes only and does not constitute legal advice. You should consult with a qualified patent attorney or agent for advice specific to your situation.

No Guarantees: We do not provide any guarantees as to the accuracy, completeness, or timeliness of the statistics presented above. Patent prosecution statistics are derived from publicly available USPTO data and are subject to data quality limitations, processing errors, and changes in USPTO practices over time.

Limitation of Liability: Under no circumstances will IronCrow AI be liable for any outcome, decision, or action resulting from your reliance on the statistics, analysis, or recommendations presented in this report. Past prosecution patterns do not guarantee future results.

Use at Your Own Risk: While we strive to provide accurate and useful prosecution statistics, you should independently verify any information that is material to your prosecution strategy and use your professional judgment in all patent prosecution matters.